Abound Wealth Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88 Hold
5
﹤0.01% 1307
2026
Q1
$83 Hold
5
﹤0.01% 1444
2025
Q4
$143 Hold
5
﹤0.01% 1304
2025
Q3
$148 Hold
5
﹤0.01% 1228
2025
Q2
$145 Hold
5
﹤0.01% 1148
2025
Q1
$175 Hold
5
﹤0.01% 1040
2024
Q4
$223 Hold
5
﹤0.01% 1011
2024
Q3
$228 Buy
5
+4
+400% +$162 ﹤0.01% 1087
2024
Q2
$34 Hold
1
﹤0.01% 1159
2024
Q1
$48 Hold
1
﹤0.01% 1283
2023
Q4
$74 Hold
1
﹤0.01% 1297
2023
Q3
$74 Hold
1
﹤0.01% 1155
2023
Q2
$83 Hold
1
﹤0.01% 1178
2023
Q1
$90 Hold
1
﹤0.01% 705
2022
Q4
$86 Hold
1
﹤0.01% 711
2022
Q3
$72 Buy
+1
New +$89 ﹤0.01% 726

Other funds holding QDEL

Abound Wealth Management's QDEL Position: Q2 2026 in Review

Abound Wealth Management held its QuidelOrtho (QDEL) position steady in Q2 2026 at 5 shares worth $88. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Abound Wealth Management first reported a position in QDEL in Q3 2022 and has held it in 16 quarters since. The position peaked at $228 in Q3 2024. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Abound Wealth Management held 5 shares of QuidelOrtho worth $88 as of Q2 2026.
  • Abound Wealth Management left its QuidelOrtho share count unchanged in Q2 2026.
  • QuidelOrtho made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1307 holding.
  • Abound Wealth Management first reported a position in QuidelOrtho in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's QuidelOrtho position peaked at $228 in Q3 2024.
  • 246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.